Global Thrombectomy Devices market is expected to reach USD 1.6 Billion by 2023.

Posted August 30, 2018 by nitesh

The Global Thrombectomy Devices market is driven by factors such as rising sedentary lifestyle, growing geriatric population, increasing demand for minimally invasive procedures
Market Overview:
In the year 2018 Global Thrombectomy Devices Market was valued at USD 1.12 billion. By the year 2023, it is predicted to reach USD 1.6 billion with pace of 7.4% CAGR.
Thrombectomy devices are used to treat blood clots present in the arteries, veins, and capillaries. Thethrombectomy devices are mainly used in the surgeries to remove blood clots which are blocking the blood circulation in the human body. These devices are used to treat various chronic diseases like acute myocardial infraction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

Request Report Sample:

Factors affecting market growth:
• Growing geriatric population across the globe. (+)
• Increasing prevalence of cerebrovascular and cardiovascular diseases. (+)
• Technological advancements in minimally invasive surgeries. (+)
• Favorable reimbursement policies. (+)
• Improving healthcare infrastructure in the developing countries. (+)
• Increasing demand for thrombectomy devices. (+)
• Strict regulatory policies. (-)
• Lack of awareness about thrombectomy treatments among global population. (-)

Get your customized report:

Market Segmentation
The Global Thrombectomy Devices Market is segmented on the basis of
• Stent Retrievers
• Basket/Brush Retrievers
• Coil Retrievers
• Mechanical Thrombectomy Devices
• Ultrasonic Thrombectomy Devices
• Aspiration Thrombectomy Devices
• Hydrodynamic Thrombectomy Devices
• Peripheral Vascular Application
• Neurovascular Application
• Cardiovascular Application
• Research Laboratories & Academic Institutes
• Ambulatory Surgical Centers
• Hospital Surgical Centers
• Coronary Diseases
• Neural Diseases
• Peripheral Diseases
Based on application, the Cardiovascular segment holds the largest market share in the global thrombectomy devices market due to increasing of aging population and growing number for cardiac surgeries and increasing preference of minimally invasive surgeries across the globe.
In the end user segment, hospital segment is rapidly growing due to improving healthcare facilities and well-organized infrastructure which is expected to gain high growth rate in the global thrombectomy devices market during the forecast period.

Browse full Table of Contents:

Key players:
Leading companies in the global thrombectomy devices market are Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), Teleflex Incorporated (U.S.), Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), and Terumo Corporation (Japan).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market data forecast
Phone 08887098757
Business Address Market Data Forecast, Inc.
Country India
Categories Health
Tags thrombectomy devices market , embolectomy market
Last Updated August 30, 2018